Michael S Greenfield, MD
Endocrinology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 4 carriers
- Office
- 1
- Since medical school
- 52 years
- Harvard Medical School, 1974
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
20 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Greenfield’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G35253 · Current
Licensed to practise in California · since 1977 · expires 2026-11-30 · Harvard Medical School. Board flags: Citation Resolved.
Public record actions
| 2025-09-03 | Citation | Section 1338(c) of Title 16, California Code of Regulations · $750 · resolved 2025-09-18 |
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$76,355
Medicare paid this office $76,355 for 216 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 213 | $68,249 | $109 |
| New patient visit (60+ min) | 21 | $4,000 | $190 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 26 | $1,249 | $30 |
Who their Medicare patients are
216 Original Medicare patients in 2024. Average age 76 · Women 63% · Health risk score 1.15. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 74% · Diabetes 51% · Chronic kidney disease 25% · Coronary heart disease 22% · Cancer 20% · Atrial fibrillation 16% · Heart failure 11% · COPD 6% · Depression 6% · Dementia 5%.
The office billed $119,377, Medicare allowed $102,988 and paid $76,355; for 737 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 216 | 737 | 76 | 1.15 | $119,377 | $76,355 |
| 2023 | 221 | 798 | 76 | 1.04 | $132,575 | $81,663 |
| 2022 | 220 | 806 | 76 | 1.07 | $134,546 | $78,596 |
| 2021 | 223 | 804 | 76 | 1.03 | $134,758 | $83,462 |
| 2020 | 208 | 870 | 76 | 1.21 | $109,316 | $54,877 |
| 2019 | 236 | 1,589 | 76 | 1.28 | $137,000 | $75,905 |
| 2018 | 239 | 1,613 | 76 | 1.29 | $139,623 | $76,925 |
| 2017 | 236 | 1,552 | 76 | 1.42 | $132,309 | $75,714 |
| 2016 | 231 | 1,458 | 76 | 1.11 | $129,510 | $77,608 |
| 2015 | 117 | 299 | 75 | 1.31 | $25,983 | $15,692 |
| 2014 | 234 | 1,365 | 76 | 1.16 | $120,242 | $72,108 |
| 2013 | 225 | 1,467 | 75 | 1.13 | $129,802 | $82,990 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 215 | $72,947 | $107 |
| New patient visit (60+ min) | 20 | $3,770 | $189 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 13 | $1,687 | $130 |
| Hemoglobin a1c level | 17 | $171 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 21 | $71 | $3 |
2022: 6 services
| Return visit (30+ min) | 210 | $67,416 | $100 |
| Ultrasound scan of head and neck soft tissue | 29 | $3,391 | $113 |
| New patient visit (60+ min) | 17 | $2,809 | $165 |
| Short return visit (20+ min) | 21 | $1,824 | $83 |
| Hemoglobin a1c level | 16 | $173 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 12 | $42 | $3 |
2021: 3 services
| Return visit (30+ min) | 220 | $77,740 | $104 |
| New patient visit (60+ min) | 17 | $3,148 | $185 |
| Hemoglobin a1c level | 11 | $136 | $10 |
2020: 6 services
| Return visit (30+ min) | 203 | $48,082 | $74 |
| New patient visit (60+ min) | 12 | $1,606 | $134 |
| Long return visit (40+ min) | 12 | $1,282 | $107 |
| Short return visit (20+ min) | 24 | $1,229 | $51 |
| Hemoglobin a1c level | 76 | $772 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 69 | $228 | $3 |
2019: 6 services
| Return visit (30+ min) | 232 | $58,768 | $85 |
| Hemoglobin a1c level | 126 | $4,097 | $11 |
| Ultrasound scan of head and neck soft tissue | 36 | $4,022 | $109 |
| New patient visit (60+ min) | 22 | $2,904 | $132 |
| Long return visit (40+ min) | 20 | $2,320 | $110 |
| Blood glucose (sugar) test performed by hand-held instrument | 124 | $1,219 | $3 |
2018: 9 services
| Return visit (30+ min) | 233 | $57,401 | $81 |
| Hemoglobin a1c level | 123 | $4,377 | $12 |
| Ultrasound scan of head and neck soft tissue | 33 | $3,484 | $106 |
| Long return visit (40+ min) | 24 | $3,392 | $126 |
| New patient visit (60+ min) | 19 | $2,729 | $144 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 15 | $2,192 | $137 |
| Blood glucose (sugar) test performed by hand-held instrument | 120 | $1,173 | $3 |
| Short return visit (20+ min) | 12 | $767 | $64 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 16 | $540 | $30 |
2017: 6 services
| Return visit (30+ min) | 225 | $55,321 | $85 |
| New patient visit (60+ min) | 31 | $5,085 | $164 |
| Hemoglobin a1c level | 117 | $4,846 | $13 |
| Ultrasound scan of head and neck soft tissue | 41 | $4,839 | $110 |
| Short return visit (20+ min) | 27 | $1,662 | $57 |
| Blood glucose (sugar) test performed by hand-held instrument | 115 | $1,144 | $3 |
2016: 6 services
| Return visit (30+ min) | 218 | $57,895 | $90 |
| Ultrasound scan of head and neck soft tissue | 46 | $5,065 | $110 |
| Hemoglobin a1c level | 112 | $4,136 | $13 |
| New patient visit (60+ min) | 22 | $3,959 | $180 |
| Short return visit (20+ min) | 29 | $2,144 | $65 |
| Blood glucose (sugar) test performed by hand-held instrument | 110 | $986 | $3 |
2015: 3 services
| Return visit (30+ min) | 97 | $10,738 | $87 |
| Hemoglobin a1c level | 47 | $712 | $13 |
| Blood glucose (sugar) test performed by hand-held instrument | 46 | $172 | $3 |
2014: 10 services
| Return visit (30+ min) | 205 | $45,564 | $84 |
| Ultrasound scan of head and neck soft tissue | 51 | $5,553 | $109 |
| New patient visit (60+ min) | 29 | $4,974 | $172 |
| Short return visit (20+ min) | 58 | $4,200 | $58 |
| Hemoglobin a1c level | 108 | $3,518 | $13 |
| Fine needle aspiration using imaging guidance | 13 | $1,939 | $129 |
| Long return visit (40+ min) | 18 | $1,799 | $100 |
| Ultrasonic guidance for needle placement | 14 | $1,093 | $68 |
| Blood glucose (sugar) test performed by hand-held instrument | 108 | $857 | $3 |
| Short return visit | 18 | $591 | $31 |
2013: 11 services
| Return visit (30+ min) | 197 | $50,627 | $86 |
| Short return visit (20+ min) | 90 | $7,029 | $54 |
| New patient visit (60+ min) | 37 | $6,486 | $175 |
| Ultrasound scan of head and neck soft tissue | 46 | $5,217 | $111 |
| Hemoglobin a1c level | 96 | $3,112 | $13 |
| Ultrasonic guidance for needle placement | 12 | $3,046 | $203 |
| Fine needle aspiration using imaging guidance | 12 | $1,948 | $130 |
| Long return visit (40+ min) | 12 | $1,377 | $115 |
| Blood glucose (sugar) test performed by hand-held instrument | 102 | $904 | $3 |
| Short return visit | 17 | $716 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $219 | $17 |
Drugs they prescribed that Part D paid
$945,708
Pharmacies billed $945,708 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,776) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,726 generic and 978 brand-name prescriptions · $945,708 in drug cost · 32 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 118 | $194,584 | $1,649 |
| Jardiance | 135 | $179,680 | $1,331 |
| Mounjaro | 67 | $87,959 | $1,313 |
| Rybelsus | 32 | $57,164 | $1,786 |
| Farxiga | 43 | $53,672 | $1,248 |
See all 45 drugs
| Ozempic | 118 | $194,584 | $1,649 |
| Jardiance | 135 | $179,680 | $1,331 |
| Mounjaro | 67 | $87,959 | $1,313 |
| Rybelsus | 32 | $57,164 | $1,786 |
| Farxiga | 43 | $53,672 | $1,248 |
| Januvia | 31 | $34,574 | $1,115 |
| Tresiba Flextouch U-100 | 44 | $33,647 | $765 |
| Tradjenta | 29 | $31,383 | $1,082 |
| Prolia | 16 | $27,596 | $1,725 |
| Genotropin | 26 | $23,931 | $920 |
| Invokana | 18 | $17,255 | $959 |
| Lyumjev | 15 | $15,116 | $1,008 |
| Synthroid | 138 | $14,709 | $107 |
| Nano 2nd Gen Pen Needle | 46 | $5,015 | $109 |
| Novolog Flexpen | 13 | $5,000 | $385 |
| Humalog Kwikpen U-100 | 19 | $4,267 | $225 |
| Rosuvastatin | 231 | $3,987 | $17 |
| Levothyroxine | 188 | $2,671 | $14 |
| Metformin Hcl Er | 150 | $2,264 | $15 |
| Metformin | 147 | $2,087 | $14 |
| Repaglinide | 42 | $2,056 | $49 |
| Estradiol (Once Weekly) | 19 | $1,409 | $74 |
| Lantus Solostar | 23 | $1,372 | $60 |
| Atorvastatin | 128 | $1,146 | $9 |
| Fenofibrate | 18 | $1,037 | $58 |
| Ezetimibe | 54 | $1,033 | $19 |
| Hydrocortisone | 20 | $941 | $47 |
| Levoxyl | 35 | $863 | $25 |
| Raloxifene | 12 | $758 | $63 |
| Losartan | 94 | $733 | $8 |
| Ramipril | 34 | $630 | $19 |
| Fenofibrate | 15 | $593 | $40 |
| Carvedilol | 40 | $507 | $13 |
| Glimepiride | 24 | $434 | $18 |
| Lisinopril | 42 | $430 | $10 |
| Simvastatin | 37 | $414 | $11 |
| Pioglitazone | 22 | $411 | $19 |
| Liothyronine | 16 | $402 | $25 |
| Amlodipine Besylate | 37 | $279 | $8 |
| Hydrochlorothiazide | 53 | $182 | $3 |
| Metoprolol | 12 | $177 | $15 |
| Alendronate | 24 | $165 | $7 |
| Irbesartan | 22 | $130 | $6 |
| Glipizide | 28 | $128 | $5 |
| Furosemide | 12 | $93 | $8 |
Year by year
| 2024 | 2,776 | 234 | 0% (0) | 35% | $945,708 |
| 2023 | 2,606 | 224 | 0% (0) | 35% | $1,035,524 |
| 2022 | 2,490 | 204 | 0% (0) | 36% | $894,465 |
| 2021 | 2,496 | 202 | 0% (0) | 34% | $806,236 |
| 2020 | 2,317 | 180 | 0% (0) | 34% | $698,448 |
| 2019 | 2,224 | 186 | 0% (0) | 35% | $587,178 |
| 2018 | 2,313 | 174 | 0% (0) | 36% | $517,462 |
| 2017 | 2,325 | 174 | None | 35% | $448,922 |
| 2016 | 2,340 | 166 | None | 39% | $416,859 |
| 2015 | 2,263 | 157 | 0% (0) | 38% | $330,463 |
| 2014 | 2,380 | 156 | None | 39% | $332,239 |
| 2013 | 2,107 | 139 | 0% (0) | 39% | $276,566 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 44 drugs
| Ozempic | 113 | $218,763 | $1,936 |
| Jardiance | 158 | $209,311 | $1,325 |
| Rybelsus | 42 | $82,405 | $1,962 |
| Farxiga | 46 | $68,985 | $1,500 |
| Mounjaro | 46 | $62,310 | $1,355 |
| Januvia | 31 | $37,654 | $1,215 |
| Tresiba Flextouch U-100 | 41 | $25,815 | $630 |
| Tradjenta | 17 | $23,292 | $1,370 |
| Invokana | 24 | $22,240 | $927 |
| Novolog Flexpen | 15 | $19,773 | $1,318 |
| Lyumjev | 16 | $19,443 | $1,215 |
| Humalog Kwikpen U-100 | 23 | $19,231 | $836 |
| Synjardy Xr | 12 | $17,486 | $1,457 |
| Synthroid | 127 | $15,260 | $120 |
| Lantus Solostar | 12 | $7,017 | $585 |
| Lyumjev Kwikpen U-100 | 11 | $6,290 | $572 |
| Carvedilol Er | 19 | $5,921 | $312 |
| Nano 2nd Gen Pen Needle | 51 | $5,136 | $101 |
| Rosuvastatin | 209 | $4,151 | $20 |
| Levothyroxine | 161 | $2,744 | $17 |
| Metformin | 147 | $2,527 | $17 |
| Metformin Hcl Er | 133 | $2,232 | $17 |
| Repaglinide | 36 | $1,963 | $55 |
| Estradiol (Once Weekly) | 17 | $1,538 | $90 |
| Atorvastatin | 109 | $1,432 | $13 |
| Ezetimibe | 32 | $1,409 | $44 |
| Fenofibrate | 18 | $1,289 | $72 |
| Losartan | 94 | $1,173 | $12 |
| Raloxifene | 15 | $1,073 | $72 |
| Glimepiride | 40 | $947 | $24 |
| Pioglitazone | 29 | $680 | $23 |
| Irbesartan | 35 | $604 | $17 |
| Liothyronine | 12 | $585 | $49 |
| Levoxyl | 34 | $580 | $17 |
| Ramipril | 40 | $530 | $13 |
| Lisinopril | 44 | $477 | $11 |
| Carvedilol | 22 | $452 | $21 |
| Fenofibrate | 16 | $377 | $24 |
| Amlodipine Besylate | 35 | $283 | $8 |
| Glipizide | 29 | $219 | $8 |
| Alendronate | 24 | $196 | $8 |
| Temazepam | 12 | $183 | $15 |
| Simvastatin | 30 | $176 | $6 |
| Hydrochlorothiazide | 45 | $147 | $3 |
2022: 47 drugs
| Jardiance | 142 | $177,431 | $1,250 |
| Ozempic | 79 | $118,418 | $1,499 |
| Rybelsus | 37 | $57,658 | $1,558 |
| Farxiga | 43 | $50,600 | $1,177 |
| Januvia | 42 | $48,748 | $1,161 |
| Tradjenta | 28 | $37,465 | $1,338 |
| Trulicity | 31 | $35,633 | $1,149 |
| Invokana | 37 | $34,788 | $940 |
| Tresiba Flextouch U-100 | 30 | $31,173 | $1,039 |
| Novolog Flexpen | 19 | $22,205 | $1,169 |
| Humalog Kwikpen U-100 | 18 | $20,719 | $1,151 |
| Synthroid | 113 | $13,879 | $123 |
| Lyumjev | 15 | $11,783 | $786 |
| Toujeo Solostar | 11 | $8,433 | $767 |
| Lantus Solostar | 16 | $7,613 | $476 |
| Rosuvastatin | 193 | $7,517 | $39 |
| Repaglinide | 28 | $6,992 | $250 |
| Levothyroxine | 130 | $2,814 | $22 |
| Nano 2nd Gen Pen Needle | 21 | $2,717 | $129 |
| Metformin | 138 | $2,080 | $15 |
| Ezetimibe | 22 | $1,959 | $89 |
| Estradiol (Twice Weekly) | 11 | $1,926 | $175 |
| Metformin Hcl Er | 100 | $1,716 | $17 |
| Ultra-Fine Mini Pen Needle | 11 | $1,619 | $147 |
| Glimepiride | 51 | $1,387 | $27 |
| Estradiol (Once Weekly) | 17 | $1,371 | $81 |
| Atorvastatin | 103 | $1,350 | $13 |
| Fenofibrate | 20 | $1,049 | $52 |
| Losartan | 79 | $950 | $12 |
| Raloxifene | 18 | $943 | $52 |
| Ramipril | 38 | $860 | $23 |
| Carvedilol | 42 | $798 | $19 |
| Fenofibrate | 14 | $707 | $50 |
| Irbesartan | 34 | $691 | $20 |
| Levoxyl | 42 | $657 | $16 |
| Pioglitazone | 31 | $592 | $19 |
| Lisinopril | 45 | $506 | $11 |
| Metoprolol | 15 | $377 | $25 |
| Pravastatin | 16 | $317 | $20 |
| Amlodipine Besylate | 39 | $299 | $8 |
| Simvastatin | 31 | $256 | $8 |
| Metoclopramide | 13 | $250 | $19 |
| Glipizide | 19 | $194 | $10 |
| Alendronate | 16 | $172 | $11 |
| Furosemide | 19 | $154 | $8 |
| Gabapentin | 17 | $150 | $9 |
| Hydrochlorothiazide | 38 | $148 | $4 |
2021: 53 drugs
| Jardiance | 113 | $149,489 | $1,323 |
| Ozempic | 33 | $63,883 | $1,936 |
| Tradjenta | 38 | $49,477 | $1,302 |
| Victoza 3-Pak | 20 | $47,522 | $2,376 |
| Januvia | 40 | $44,377 | $1,109 |
| Trulicity | 32 | $39,691 | $1,240 |
| Farxiga | 35 | $38,016 | $1,086 |
| Rybelsus | 37 | $36,198 | $978 |
| Tresiba Flextouch U-100 | 37 | $30,398 | $822 |
| Invokana | 26 | $30,056 | $1,156 |
| Synjardy Xr | 13 | $19,991 | $1,538 |
| Novolog Flexpen | 14 | $18,655 | $1,333 |
| Synthroid | 135 | $14,476 | $107 |
| Humalog Kwikpen U-100 | 12 | $12,380 | $1,032 |
| Lantus Solostar | 21 | $12,239 | $583 |
| Nexletol | 13 | $5,467 | $421 |
| Rosuvastatin | 156 | $5,058 | $32 |
| Repaglinide | 29 | $4,775 | $165 |
| Ezetimibe | 39 | $3,131 | $80 |
| Levothyroxine | 103 | $2,461 | $24 |
| Estradiol | 11 | $2,457 | $223 |
| Metformin Hcl Er | 118 | $2,047 | $17 |
| Irbesartan | 36 | $1,958 | $54 |
| Novofine 32 | 22 | $1,954 | $89 |
| Estradiol (Once Weekly) | 17 | $1,845 | $109 |
| Metformin | 141 | $1,843 | $13 |
| Raloxifene | 20 | $1,809 | $90 |
| Glimepiride | 73 | $1,551 | $21 |
| Eplerenone | 12 | $1,341 | $112 |
| Estradiol (Twice Weekly) | 17 | $1,308 | $77 |
| Atorvastatin | 84 | $1,287 | $15 |
| Nano 2nd Gen Pen Needle | 16 | $1,248 | $78 |
| Losartan | 73 | $1,111 | $15 |
| Liothyronine | 12 | $1,057 | $88 |
| Fenofibrate | 18 | $985 | $55 |
| Pioglitazone | 40 | $941 | $24 |
| Levoxyl | 43 | $930 | $22 |
| Fenofibrate | 16 | $823 | $51 |
| Lisinopril | 45 | $710 | $16 |
| Carvedilol | 35 | $693 | $20 |
| Ramipril | 39 | $688 | $18 |
| Bupropion Xl | 13 | $606 | $47 |
| Metoclopramide | 15 | $489 | $33 |
| Pravastatin | 19 | $455 | $24 |
| Simvastatin | 45 | $426 | $9 |
| Glipizide | 25 | $418 | $17 |
| Metoprolol | 17 | $406 | $24 |
| Methimazole | 17 | $370 | $22 |
| Amlodipine Besylate | 41 | $310 | $8 |
| Hydrochlorothiazide | 44 | $308 | $7 |
| Alendronate | 18 | $162 | $9 |
| Furosemide | 11 | $154 | $14 |
| Euthyrox | 15 | $128 | $9 |
2020: 48 drugs
| Jardiance | 89 | $117,236 | $1,317 |
| Ozempic | 29 | $50,312 | $1,735 |
| Victoza 3-Pak | 21 | $49,914 | $2,377 |
| Tradjenta | 51 | $47,646 | $934 |
| Invokana | 37 | $39,791 | $1,075 |
| Januvia | 29 | $38,219 | $1,318 |
| Trulicity | 26 | $37,622 | $1,447 |
| Farxiga | 22 | $17,619 | $801 |
| Tresiba Flextouch U-100 | 30 | $15,491 | $516 |
| Humalog Kwikpen U-100 | 14 | $14,803 | $1,057 |
| Synthroid | 156 | $14,704 | $94 |
| Synjardy Xr | 12 | $14,449 | $1,204 |
| Humalog | 12 | $11,214 | $934 |
| Lantus Solostar | 15 | $9,605 | $640 |
| Rosuvastatin | 152 | $6,876 | $45 |
| Repaglinide | 25 | $3,652 | $146 |
| Raloxifene | 21 | $2,671 | $127 |
| Levothyroxine | 90 | $2,626 | $29 |
| Ezetimibe | 25 | $1,940 | $78 |
| Metformin Hcl Er | 87 | $1,673 | $19 |
| Metformin | 135 | $1,602 | $12 |
| Irbesartan | 23 | $1,500 | $65 |
| Atorvastatin | 99 | $1,491 | $15 |
| Estradiol (Once Weekly) | 15 | $1,123 | $75 |
| Ultra-Fine Mini Pen Needle | 13 | $1,040 | $80 |
| Levoxyl | 32 | $1,019 | $32 |
| Glimepiride | 77 | $1,018 | $13 |
| Fenofibrate | 14 | $966 | $69 |
| Ramipril | 37 | $884 | $24 |
| Losartan | 67 | $845 | $13 |
| Fenofibrate | 22 | $819 | $37 |
| Carvedilol | 34 | $780 | $23 |
| Pioglitazone | 28 | $755 | $27 |
| Simvastatin | 56 | $635 | $11 |
| Metoprolol | 26 | $607 | $23 |
| Hydrocortisone | 12 | $578 | $48 |
| Lisinopril | 45 | $566 | $13 |
| Alfuzosin Hcl Er | 13 | $420 | $32 |
| Amlodipine Besylate | 39 | $359 | $9 |
| Pravastatin | 15 | $355 | $24 |
| Glipizide | 33 | $318 | $10 |
| Hydrochlorothiazide | 40 | $293 | $7 |
| Metoclopramide | 15 | $249 | $17 |
| Alendronate | 19 | $244 | $13 |
| Furosemide | 13 | $205 | $16 |
| Methimazole | 12 | $176 | $15 |
| Gabapentin | 15 | $175 | $12 |
| Benazepril | 11 | $126 | $11 |
2019: 52 drugs
| Jardiance | 86 | $88,921 | $1,034 |
| Trulicity | 28 | $42,479 | $1,517 |
| Victoza 3-Pak | 18 | $41,949 | $2,331 |
| Januvia | 33 | $35,766 | $1,084 |
| Tradjenta | 49 | $35,265 | $720 |
| Invokana | 28 | $28,761 | $1,027 |
| Humalog Kwikpen U-100 | 23 | $23,923 | $1,040 |
| Ozempic | 22 | $22,473 | $1,022 |
| Humalog | 19 | $15,435 | $812 |
| Genotropin | 11 | $14,116 | $1,283 |
| Synthroid | 153 | $14,081 | $92 |
| Tresiba Flextouch U-100 | 18 | $13,565 | $754 |
| Farxiga | 16 | $12,856 | $803 |
| Synjardy Xr | 12 | $11,596 | $966 |
| Xultophy 100-3.6 | 13 | $10,400 | $800 |
| Lantus | 11 | $10,154 | $923 |
| Rosuvastatin | 95 | $4,333 | $46 |
| Estradiol | 43 | $3,920 | $91 |
| Levothyroxine | 99 | $2,616 | $26 |
| Raloxifene | 18 | $2,223 | $124 |
| Ezetimibe | 26 | $1,938 | $75 |
| Metformin | 136 | $1,688 | $12 |
| Progesterone | 13 | $1,620 | $125 |
| Glimepiride | 67 | $1,597 | $24 |
| Metformin Hcl Er | 75 | $1,540 | $21 |
| Atorvastatin | 89 | $1,424 | $16 |
| Ramipril | 42 | $1,354 | $32 |
| Potassium Chloride | 14 | $1,283 | $92 |
| Repaglinide | 22 | $1,114 | $51 |
| Ultra-Fine Nano Pen Needle | 15 | $1,055 | $70 |
| Irbesartan | 28 | $965 | $34 |
| Levoxyl | 35 | $894 | $26 |
| Lisinopril | 48 | $720 | $15 |
| Carvedilol | 33 | $710 | $22 |
| Fenofibrate | 11 | $678 | $62 |
| Liothyronine | 14 | $672 | $48 |
| Simvastatin | 58 | $671 | $12 |
| Losartan | 48 | $632 | $13 |
| Metoprolol | 21 | $584 | $28 |
| Pioglitazone | 24 | $544 | $23 |
| Fenofibrate | 12 | $542 | $45 |
| Pravastatin | 19 | $539 | $28 |
| Alfuzosin Hcl Er | 12 | $487 | $41 |
| Hydrochlorothiazide | 42 | $445 | $11 |
| Amlodipine Besylate | 29 | $411 | $14 |
| Gabapentin | 23 | $398 | $17 |
| Alendronate | 29 | $370 | $13 |
| Methimazole | 17 | $328 | $19 |
| Glipizide | 36 | $291 | $8 |
| Spironolactone | 12 | $277 | $23 |
| Furosemide | 15 | $273 | $18 |
| Metoclopramide | 11 | $105 | $10 |
2018: 50 drugs
| Victoza 3-Pak | 24 | $46,285 | $1,929 |
| Jardiance | 46 | $36,539 | $794 |
| Trulicity | 20 | $36,296 | $1,815 |
| Tradjenta | 62 | $35,938 | $580 |
| Invokana | 40 | $35,236 | $881 |
| Humalog Kwikpen U-100 | 38 | $32,565 | $857 |
| Januvia | 25 | $26,195 | $1,048 |
| Humalog | 24 | $17,343 | $723 |
| Synthroid | 199 | $16,256 | $82 |
| Lantus Solostar | 24 | $14,557 | $607 |
| Genotropin | 12 | $13,922 | $1,160 |
| Androgel | 14 | $13,612 | $972 |
| Lantus | 20 | $11,912 | $596 |
| Tresiba Flextouch U-100 | 12 | $9,864 | $822 |
| Rosuvastatin | 86 | $4,052 | $47 |
| Raloxifene | 24 | $3,666 | $153 |
| Levothyroxine | 92 | $2,362 | $26 |
| Estradiol | 18 | $2,252 | $125 |
| Ezetimibe | 24 | $2,252 | $94 |
| Atorvastatin | 98 | $1,910 | $19 |
| Desmopressin Acetate | 11 | $1,873 | $170 |
| Metformin | 121 | $1,627 | $13 |
| Ramipril | 47 | $1,615 | $34 |
| Climara | 12 | $1,552 | $129 |
| Repaglinide | 27 | $1,551 | $57 |
| Glimepiride | 51 | $1,260 | $25 |
| Pravastatin | 38 | $1,207 | $32 |
| Potassium Chloride | 11 | $1,207 | $110 |
| Levoxyl | 38 | $921 | $24 |
| Gabapentin | 50 | $833 | $17 |
| Carvedilol | 49 | $800 | $16 |
| Metformin Hcl Er | 59 | $764 | $13 |
| Simvastatin | 74 | $755 | $10 |
| Fenofibrate | 20 | $707 | $35 |
| Alendronate | 27 | $518 | $19 |
| Losartan | 44 | $490 | $11 |
| Alfuzosin Hcl Er | 14 | $472 | $34 |
| Hydrocortisone | 13 | $465 | $36 |
| Lisinopril | 41 | $413 | $10 |
| Amlodipine Besylate | 34 | $398 | $12 |
| Methimazole | 23 | $387 | $17 |
| Irbesartan | 15 | $343 | $23 |
| Hydrochlorothiazide | 56 | $317 | $6 |
| Liothyronine | 15 | $312 | $21 |
| Metoprolol | 13 | $310 | $24 |
| Pioglitazone | 24 | $286 | $12 |
| Glipizide | 32 | $237 | $7 |
| Furosemide | 11 | $194 | $18 |
| Lovastatin | 15 | $95 | $6 |
| Metoprolol | 13 | $50 | $4 |
2017: 51 drugs
| Victoza 3-Pak | 31 | $47,194 | $1,522 |
| Jardiance | 42 | $29,325 | $698 |
| Tradjenta | 47 | $24,832 | $528 |
| Humalog Kwikpen U-100 | 40 | $24,485 | $612 |
| Januvia | 24 | $23,039 | $960 |
| Genotropin | 14 | $21,980 | $1,570 |
| Invokana | 27 | $16,883 | $625 |
| Androgel | 17 | $15,753 | $927 |
| Humalog | 25 | $15,365 | $615 |
| Synthroid | 191 | $15,066 | $79 |
| Repatha Sureclick | 12 | $13,543 | $1,129 |
| Lantus Solostar | 29 | $11,499 | $397 |
| Zetia | 13 | $8,109 | $624 |
| Lantus | 15 | $7,971 | $531 |
| Levemir Flextouch | 12 | $7,283 | $607 |
| Novolog Flexpen | 12 | $6,487 | $541 |
| Repaglinide | 23 | $4,659 | $203 |
| Rosuvastatin | 72 | $4,440 | $62 |
| Estradiol | 36 | $3,465 | $96 |
| Levothyroxine | 111 | $2,864 | $26 |
| Metformin | 133 | $1,684 | $13 |
| Ezetimibe | 13 | $1,556 | $120 |
| Ramipril | 49 | $1,390 | $28 |
| Desmopressin Acetate | 13 | $1,315 | $101 |
| Atorvastatin | 89 | $1,273 | $14 |
| Pravastatin | 32 | $1,259 | $39 |
| Ultra-Fine Nano Pen Needle | 20 | $1,253 | $63 |
| Levoxyl | 35 | $1,130 | $32 |
| Novofine 32 | 18 | $1,095 | $61 |
| Glimepiride | 56 | $970 | $17 |
| Fenofibrate | 26 | $929 | $36 |
| Progesterone | 12 | $851 | $71 |
| Potassium Chloride | 13 | $847 | $65 |
| Methimazole | 25 | $789 | $32 |
| Simvastatin | 84 | $788 | $9 |
| Carvedilol | 56 | $735 | $13 |
| Fenofibrate | 12 | $702 | $58 |
| Metformin Hcl Er | 46 | $670 | $15 |
| Pioglitazone | 31 | $663 | $21 |
| Irbesartan | 16 | $581 | $36 |
| Alfuzosin Hcl Er | 18 | $577 | $32 |
| Metoprolol | 18 | $476 | $26 |
| Gabapentin | 31 | $464 | $15 |
| Lisinopril | 57 | $448 | $8 |
| Alendronate | 25 | $437 | $17 |
| Losartan | 44 | $364 | $8 |
| Allopurinol | 12 | $284 | $24 |
| Glipizide | 32 | $281 | $9 |
| Hydrochlorothiazide | 57 | $226 | $4 |
| Amlodipine Besylate | 22 | $213 | $10 |
| Furosemide | 13 | $191 | $15 |
2016: 54 drugs
| Victoza 3-Pak | 27 | $34,386 | $1,274 |
| Invokana | 35 | $29,562 | $845 |
| Januvia | 43 | $26,271 | $611 |
| Crestor | 46 | $24,624 | $535 |
| Victoza 2-Pak | 23 | $22,638 | $984 |
| Humalog Kwikpen U-100 | 34 | $18,401 | $541 |
| Genotropin | 17 | $18,269 | $1,075 |
| Synthroid | 237 | $16,323 | $69 |
| Tradjenta | 23 | $15,126 | $658 |
| Androgel | 23 | $12,871 | $560 |
| Levemir Flextouch | 22 | $11,735 | $533 |
| Lantus Solostar | 27 | $10,481 | $388 |
| Humalog | 20 | $9,811 | $491 |
| Vytorin | 12 | $9,157 | $763 |
| Zetia | 14 | $8,207 | $586 |
| Kombiglyze Xr | 15 | $8,203 | $547 |
| Jardiance | 18 | $8,183 | $455 |
| Niacin Er | 17 | $4,408 | $259 |
| Diltiazem 24hr Er | 14 | $2,697 | $193 |
| Estradiol | 38 | $2,361 | $62 |
| Levothyroxine | 89 | $2,069 | $23 |
| Desmopressin Acetate | 20 | $2,031 | $102 |
| Repaglinide | 25 | $1,991 | $80 |
| Metformin | 126 | $1,628 | $13 |
| Ramipril | 49 | $1,526 | $31 |
| Pravastatin | 46 | $1,415 | $31 |
| Bd Ultra-Fine Pen Needle | 33 | $1,410 | $43 |
| Atorvastatin | 67 | $1,406 | $21 |
| Potassium Chloride | 20 | $1,338 | $67 |
| Rosuvastatin | 17 | $1,175 | $69 |
| Progesterone | 20 | $1,132 | $57 |
| Novofine 32 | 18 | $1,119 | $62 |
| Diphenoxylate-Atropine | 11 | $939 | $85 |
| Carvedilol | 61 | $879 | $14 |
| Pioglitazone | 33 | $865 | $26 |
| Simvastatin | 95 | $850 | $9 |
| Fenofibrate | 20 | $839 | $42 |
| Glimepiride | 53 | $734 | $14 |
| Irbesartan | 14 | $664 | $47 |
| Levoxyl | 26 | $663 | $26 |
| Metformin Hcl Er | 47 | $648 | $14 |
| Hydrocortisone | 18 | $595 | $33 |
| Alfuzosin Hcl Er | 17 | $591 | $35 |
| Enalapril Maleate | 17 | $556 | $33 |
| Gabapentin | 30 | $516 | $17 |
| Lisinopril | 59 | $480 | $8 |
| Methimazole | 28 | $434 | $15 |
| Alendronate | 39 | $363 | $9 |
| Losartan | 28 | $351 | $13 |
| Metoprolol | 11 | $300 | $27 |
| Furosemide | 23 | $251 | $11 |
| Amlodipine Besylate | 21 | $231 | $11 |
| Hydrochlorothiazide | 43 | $177 | $4 |
| Glipizide | 14 | $110 | $8 |
2015: 54 drugs
| Crestor | 81 | $29,486 | $364 |
| Invokana | 39 | $25,077 | $643 |
| Victoza 3-Pak | 23 | $24,641 | $1,071 |
| Victoza 2-Pak | 28 | $19,674 | $703 |
| Januvia | 38 | $15,330 | $403 |
| Novolog Flexpen | 34 | $14,402 | $424 |
| Synthroid | 243 | $13,546 | $56 |
| Tradjenta | 19 | $11,459 | $603 |
| Onglyza | 18 | $10,597 | $589 |
| Lantus Solostar | 25 | $9,310 | $372 |
| Levemir Flextouch | 21 | $8,988 | $428 |
| Humalog | 16 | $6,609 | $413 |
| Nexium | 12 | $6,311 | $526 |
| Androgel | 13 | $5,969 | $459 |
| Zetia | 13 | $5,898 | $454 |
| Niacin Er | 16 | $4,413 | $276 |
| Desmopressin Acetate | 18 | $2,262 | $126 |
| Estradiol | 41 | $2,162 | $53 |
| Pioglitazone | 46 | $1,976 | $43 |
| Ramipril | 64 | $1,926 | $30 |
| Butalbital-Aspirin-Caffeine | 11 | $1,749 | $159 |
| Repaglinide | 21 | $1,712 | $82 |
| Levothyroxine | 81 | $1,591 | $20 |
| Pravastatin | 39 | $1,514 | $39 |
| Bd Ultra-Fine Pen Needle | 38 | $1,434 | $38 |
| Atorvastatin | 75 | $1,403 | $19 |
| Metformin Hcl Er | 56 | $1,193 | $21 |
| Metformin | 90 | $1,128 | $13 |
| Novofine 32 | 18 | $990 | $55 |
| Progesterone | 18 | $832 | $46 |
| Simvastatin | 92 | $817 | $9 |
| Carvedilol | 74 | $720 | $10 |
| Enalapril Maleate | 15 | $711 | $47 |
| Gabapentin | 19 | $657 | $35 |
| Irbesartan | 19 | $561 | $30 |
| Valsartan-Hydrochlorothiazide | 12 | $529 | $44 |
| Lisinopril | 60 | $514 | $9 |
| Alendronate | 47 | $513 | $11 |
| Butalbital-Acetaminophen-Caffe | 11 | $504 | $46 |
| Fenofibrate | 21 | $504 | $24 |
| Novotwist | 11 | $473 | $43 |
| Glimepiride | 49 | $431 | $9 |
| Methimazole | 34 | $425 | $12 |
| Irbesartan-Hydrochlorothiazide | 12 | $383 | $32 |
| Levoxyl | 20 | $288 | $14 |
| Amlodipine Besylate | 30 | $287 | $10 |
| Losartan | 22 | $233 | $11 |
| Alfuzosin Hcl Er | 12 | $230 | $19 |
| Furosemide | 11 | $222 | $20 |
| Hydrochlorothiazide | 44 | $196 | $4 |
| Glipizide | 15 | $189 | $13 |
| Anastrozole | 11 | $81 | $7 |
| Ranitidine | 13 | $75 | $6 |
| Metoprolol | 17 | $47 | $3 |
2014: 61 drugs
| Victoza 3-Pak | 39 | $30,107 | $772 |
| Crestor | 78 | $24,692 | $317 |
| Victoza 2-Pak | 33 | $17,118 | $519 |
| Tradjenta | 39 | $15,787 | $405 |
| Januvia | 37 | $15,514 | $419 |
| Invokana | 30 | $13,771 | $459 |
| Onglyza | 22 | $12,180 | $554 |
| Synthroid | 258 | $11,653 | $45 |
| Nexium | 12 | $10,316 | $860 |
| Novolog Flexpen | 23 | $8,326 | $362 |
| Janumet Xr | 17 | $8,041 | $473 |
| Zetia | 15 | $7,612 | $507 |
| Pioglitazone | 53 | $6,695 | $126 |
| Vytorin | 14 | $6,528 | $466 |
| Humalog | 18 | $6,512 | $362 |
| Androgel | 16 | $6,303 | $394 |
| Lantus Solostar | 18 | $5,712 | $317 |
| Lantus | 16 | $5,659 | $354 |
| Kombiglyze Xr | 12 | $5,358 | $447 |
| Welchol | 11 | $4,279 | $389 |
| Ramipril | 82 | $3,858 | $47 |
| Fenofibrate | 12 | $3,685 | $307 |
| Niaspan | 14 | $3,166 | $226 |
| Repaglinide | 19 | $2,595 | $137 |
| Pravastatin | 60 | $2,366 | $39 |
| Metformin | 131 | $2,098 | $16 |
| Potassium Chloride | 12 | $1,837 | $153 |
| Cabergoline | 15 | $1,645 | $110 |
| Desmopressin Acetate | 16 | $1,501 | $94 |
| Estradiol | 32 | $1,445 | $45 |
| Levothyroxine | 90 | $1,311 | $15 |
| Bd Ultra-Fine Pen Needle | 27 | $1,168 | $43 |
| Irbesartan | 22 | $1,119 | $51 |
| Simvastatin | 87 | $1,056 | $12 |
| Carvedilol | 83 | $1,042 | $13 |
| Glimepiride | 60 | $1,016 | $17 |
| Irbesartan-Hydrochlorothiazide | 14 | $1,012 | $72 |
| Atorvastatin | 47 | $1,003 | $21 |
| Butalbital-Aspirin-Caffeine | 11 | $927 | $84 |
| Valsartan-Hydrochlorothiazide | 17 | $840 | $49 |
| Novofine 32 | 15 | $663 | $44 |
| Metformin Hcl Er | 29 | $553 | $19 |
| Progesterone | 12 | $508 | $42 |
| Losartan | 33 | $492 | $15 |
| Novotwist | 12 | $490 | $41 |
| Gabapentin | 34 | $483 | $14 |
| Alendronate | 44 | $450 | $10 |
| Lisinopril | 56 | $447 | $8 |
| Fenofibrate | 20 | $372 | $19 |
| Methimazole | 34 | $370 | $11 |
| Alfuzosin Hcl Er | 17 | $357 | $21 |
| Lidocaine-Prilocaine | 12 | $259 | $22 |
| Enalapril Maleate | 13 | $250 | $19 |
| Amlodipine Besylate | 23 | $241 | $10 |
| Hydrochlorothiazide | 41 | $195 | $5 |
| Furosemide | 15 | $178 | $12 |
| Glipizide | 16 | $167 | $10 |
| Ranitidine | 12 | $67 | $6 |
| Metoprolol | 18 | $62 | $3 |
| Propranolol | 13 | $52 | $4 |
| Clonidine | 12 | $42 | $4 |
2013: 55 drugs
| Crestor | 75 | $21,141 | $282 |
| Januvia | 47 | $20,270 | $431 |
| Sensipar | 11 | $15,089 | $1,372 |
| Victoza 2-Pak | 30 | $13,922 | $464 |
| Victoza 3-Pak | 20 | $12,278 | $614 |
| Tradjenta | 30 | $10,509 | $350 |
| Novolog Flexpen | 20 | $7,445 | $372 |
| Onglyza | 18 | $7,307 | $406 |
| Synthroid | 180 | $7,286 | $40 |
| Lantus | 27 | $6,961 | $258 |
| Pioglitazone | 47 | $6,553 | $139 |
| Prandin | 16 | $5,996 | $375 |
| Vytorin | 12 | $5,467 | $456 |
| Zetia | 13 | $5,237 | $403 |
| Diovan | 15 | $4,771 | $318 |
| Niaspan | 17 | $4,637 | $273 |
| Androgel | 12 | $4,200 | $350 |
| Humalog | 15 | $4,125 | $275 |
| Lantus Solostar | 13 | $3,987 | $307 |
| Novolog | 11 | $3,982 | $362 |
| Byetta | 11 | $3,775 | $343 |
| Welchol | 12 | $3,646 | $304 |
| Humulin N | 12 | $3,214 | $268 |
| Ramipril | 75 | $2,657 | $35 |
| Irbesartan | 27 | $2,606 | $97 |
| Metformin | 138 | $2,388 | $17 |
| Estradiol | 29 | $1,987 | $69 |
| Desmopressin Acetate | 18 | $1,937 | $108 |
| Atorvastatin | 42 | $1,629 | $39 |
| Irbesartan-Hydrochlorothiazide | 16 | $1,621 | $101 |
| Cabergoline | 13 | $1,357 | $104 |
| Carvedilol | 78 | $1,156 | $15 |
| Glimepiride | 74 | $1,116 | $15 |
| Metformin Hcl Er | 38 | $1,065 | $28 |
| Simvastatin | 78 | $1,024 | $13 |
| Pravastatin | 52 | $1,017 | $20 |
| Fenofibrate | 23 | $893 | $39 |
| Progesterone | 13 | $864 | $66 |
| Levothyroxine | 83 | $830 | $10 |
| Bd Ultra-Fine Pen Needle | 17 | $727 | $43 |
| Losartan | 28 | $542 | $19 |
| Lisinopril | 40 | $539 | $13 |
| Novofine 32 | 13 | $514 | $40 |
| Novotwist | 13 | $511 | $39 |
| Hydrochlorothiazide | 43 | $376 | $9 |
| Methimazole | 22 | $352 | $16 |
| Enalapril Maleate | 20 | $284 | $14 |
| Alendronate | 19 | $272 | $14 |
| Amlodipine Besylate | 17 | $206 | $12 |
| Atenolol | 19 | $177 | $9 |
| Gabapentin | 13 | $150 | $12 |
| Glipizide | 11 | $140 | $13 |
| Ranitidine | 22 | $136 | $6 |
| Furosemide | 12 | $112 | $9 |
| Metoprolol | 17 | $110 | $6 |
Money from drug and device companies
$217 in 2025
| 2025 | 6 | 10 | None | $217 |
| 2024 | 3 | 6 | None | $100 |
| 2023 | 10 | 16 | None | $354 |
| 2022 | 8 | 12 | None | $212 |
| 2021 | 4 | 7 | None | $154 |
| 2020 | 11 | 16 | None | $320 |
| 2019 | 18 | 112 | None | $2,350 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Repatha | $75 | 3 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $47 | 2 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $35 | 2 payments
|
| Neurocrine BioSciences | Crenessity | $24 | 1 payment
|
| Agios Pharmaceuticals | Pyrukynd | $20 | 1 payment
|
| Currax Pharmaceuticals | Contrave | $16 | 1 payment
|
See all 10 published payments
| Currax Pharmaceuticals | Meals · 2025-12-22 | Contrave | $16 |
| Madrigal Pharmaceuticals | Meals · 2025-12-04 | Rezdiffra | $23 |
| Amgen | Meals · 2025-11-10 | Repatha | $16 |
| Madrigal Pharmaceuticals | Meals · 2025-11-06 | Rezdiffra | $23 |
| Amgen | Meals · 2025-09-17 | Repatha | $33 |
| Abbott Laboratories | Meals · 2025-08-06 | Freestyle Libre 3 | $15 |
| Agios Pharmaceuticals | Meals · 2025-07-31 | Pyrukynd | $20 |
| Neurocrine BioSciences | Education · 2025-07-28 | Crenessity | $24 |
| Amgen | Meals · 2025-04-02 | Evenity | $26 |
| Abbott Laboratories | Meals · 2025-02-07 | Freestyle Libre 3 | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $100
| Abbott Laboratories | Freestyle Libre 3 | $54 | 3 payments
|
| Abbvie | Synthroid | $33 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $13 | 1 payment
|
2023: $354
| Lilly USA | Jardiance | $74 | 3 payments
|
| Sanofi-Aventis U.S. | Tzield | $51 | 2 payments
|
| Currax Pharmaceuticals | Nexletol | $50 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $33 | 1 payment
|
| Novo Nordisk | Rybelsus | $32 | 2 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $31 | 2 payments
|
| MannKind | Afrezza | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
| Radius Health | Tymlos | $18 | 1 payment
|
| Abbvie | Synthroid | $16 | 1 payment
|
2022: $212
| Abbott Laboratories | Freestyle Libre 2 | $44 | 2 payments
|
| Mannkind | Afrezza | $36 | 2 payments
|
| Novo Nordisk | Rybelsus | $36 | 2 payments
|
| Lilly USA | Jardiance | $30 | 2 payments
|
| Becton Dickinson and | Bd Nano 2nd Gen Pen Needle | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $14 | 1 payment
|
| Abbvie | Synthroid | $12 | 1 payment
|
2021: $154
| Becton Dickinson and | Bd Nano | $71 | 3 payments
|
| Endo Pharmaceuticals | Edex | $45 | 2 payments
|
| Novo Nordisk | Rybelsus | $21 | 1 payment
|
| Insulet | Omnipod | $16 | 1 payment
|
2020: $320
| Endo Pharmaceuticals | Aveed | $91 | 4 payments
|
| AbbVie | Synthroid | $41 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $37 | 2 payments
|
| Amgen | Evenity | $25 | 1 payment
|
| LifeScan | Ot Verio Reflect "One Touch Meter and Strips" | $25 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $25 | 1 payment
|
| Lilly USA | Trulicity | $22 | 1 payment
|
| Corcept Therapeutics | Korlym | $18 | 1 payment
|
| Mannkind | Afrezza | $17 | 1 payment
|
| Insulet | Omnipod | $14 | 1 payment
|
| Senseonics | Eversense | $5 | 1 payment
|
2019: $2,350
| Mannkind | Afrezza | $424 | 16 payments
|
| Novo Nordisk | Ozempic | $347 | 18 payments
|
| Amgen | Evenity | $277 | 17 payments
|
| Radius Health | Tymlos | $248 | 8 payments
|
| Sanofi-Aventis U.S. | Toujeo | $171 | 8 payments
|
| Insulet | Omnipod | $145 | 10 payments
|
| AbbVie | Synthroid | $127 | 6 payments
|
| Corcept Therapeutics | Korlym | $110 | 5 payments
|
| Shire North American Group | Natpara (Parathyroid Hormone) | $99 | 4 payments
|
| Lilly USA | Humulin | $85 | 4 payments
|
| Merck Sharp & Dohme | Januvia | $85 | 5 payments
|
| Alexion Pharmaceuticals | Strensiq | $65 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $45 | 2 payments
|
| Janssen Pharmaceuticals | Invokana | $36 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Bydureon | $26 | 1 payment
|
| Vivus | Qsymia | $23 | 1 payment
|
| LifeScan | Onetouch | $19 | 1 payment
|
| Medtronic MiniMed | Minimed 670g System | $17 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Novo Nordisk Inc · Insulin Degludec Titration Using Mobile Insulin Dosing System · 2019 | Their institution | $627,374 |
Checkups this office reported
9 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 74.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 48%That's less than half. | 87 |
| Colon cancer screeningEligible adults who got a colon cancer test | 31%That's less than half. | 142 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 0%That's few of the people this applied to. | 79 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 16%That's few of the people this applied to. Better on this measure. | 79 |
| Medications listed in the chartVisits where the current medication list was documented | 97%That's most of the people this applied to. | 297 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 130 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 18% | 50 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 72%That's more than half. | 155 |
See the other 1 measures
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 30%That's less than half. | 74 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Professional record
- NPI
- 1295873685
- Licence
- CA G35253California G35253: Current · expires 2026-11-30
- Trained
- Harvard Medical School, 1974 · 52 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 2500 Hospital Dr, Building 14, Mountain View, CA, 94040
- NPI first listed
- 2007-02-01
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.